UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000003313
Receipt No. R000003989
Scientific Title Multicenter Phase II study of erlotinib for advanced or recurrent non-small cell lung cancer with Epidermal Growth factor Receptor (EGFR) mutation (TORG0911)
Date of disclosure of the study information 2010/03/14
Last modified on 2019/02/25 10:02:50

No. Disposal Last modified on Item of update
1 Insert 2010/03/11 12:36:52
2 Update 2010/05/19 10:32:08 Public title
Public title
Acronym
Acronym
3 Update 2010/05/19 10:33:15 Recruitment status
4 Update 2012/03/13 11:18:28 Name of person sending information
Organization
Division name
Address
TEL
Post marketing survey by drug manufacture etc., specified by Japanese law.
5 Update 2013/08/02 13:50:35 Recruitment status
6 Update 2014/04/21 10:48:21 Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
7 Update 2014/07/18 10:53:07 Email
8 Update 2014/12/03 13:18:52 Recruitment status
9 Update 2015/11/16 12:48:07 Publication of results
URL related to results and publications
10 Update 2016/05/19 13:49:53 Recruitment status
11 Update 2016/05/19 13:50:38 Name of primary sponsor
Organization
Category of Funding Organization
12 Update 2019/02/25 10:02:50 Recruitment status


Contact us.